CDMRP Breast Cancer Breakthrough Award Levels 1 and 2

קרןUS Department of Defense
סוגResearch Grants
תאריך אחרון16/05/2018
פקולטהLife Sciences, Medicine

Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome.


Level 1:
Innovative, high-risk/high-reward research that is in the earliest stages of idea development. Research with potential to yield new avenues of investigation. Proof of concept. No preliminary data required.
Funding: $375,000 total (if submitting with Co-PI $600,000)


Level 2: 
Research that is already supported by preliminary data and has potential to make significant advancements toward clinical translation. Demonstration of efficacy in in vivo models, as applicable.
Funding: $750,000 total (if submitting with Co-PI $1,000,000)


Duration: 3 years


Research Authority due date: 9.5.18
​Pre propsal (required)  due date: 16.5.18
Full proposal due date: 30.5.18

קבצים מצורפים
עדכון אחרוןעדכון אחרון: 09/04/2018
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive